We thought the answer was YES or CAN'T TELL.
There is little information in the article on resources, how they were measured or prices. Nonetheless the article refers to references in the public domain and in particular the technical report.
The opportunity cost is implicitly considered when producing a cost/QALY because a QALY in one disease or condition is equivalent to a QALY from a different disease or decision.
(The patient perspective and societal perspective may also be important depending on the context of the decision being made.)